Full history for every metric is available with a Kvantra account
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. (002118.SZ)
Key financial summary
Financials in CNY| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | CNY m | 1,327 | 1,325 | 859 | 286 | 247 | 144 | 150 |
| Operating profit | CNY m | -199 | -694 | |||||
| Net profit | CNY m | 372 | 174 | 70 | -706 | -998 | -1,189 | -1,082 |
| EPS reported | CNY | -0.93 | -0.85 | |||||
| Operating cashflow per share | CNY | -0.00 | -0.00 | |||||
| Capex per share | CNY | 0.00 | 0.00 | |||||
| FCF per share | CNY | -0.00 | -0.00 | |||||
| Free cash flow | CNY m | -6 | -1,087 | |||||
| Net debt | CNY m | 6,712 | 6,755 | |||||
| Book value equity | CNY m | 1,567 | 1,359 | |||||
| Book value per share | CNY | 1.23 | 1.05 | |||||
| Number of shares | m | 1,278.76 | 1,294 | |||||
| DPS (TTM paid) | CNY | 0.00 | 0.00 |
Financial summary
Financials in CNY| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 1.90 | 0.35 | |||||
| P/S LTM | x | 20.76 | 3.16 | |||||
| P/FCF LTM | x | -493.71 | -0.44 | |||||
| EV/EBITDA LTM | x | -15.66 | -14.86 | |||||
| EV/Sales LTM | x | 67.53 | 48.22 | |||||
| Earnings Yield LTM | % | -39.91% | -251.35% | |||||
| FCF Yield | % | -0.20% | -229.40% | |||||
| Quality | ||||||||
| ROE | % | -75.90% | -55.05% | |||||
| ROIC | % | -2.33% | -2.33% | |||||
| Operating margin | % | -138.95% | -138.95% | |||||
| Gross margin | % | 65.08% | 65.08% | |||||
| FCF/Sales | % | -4.21% | -4.21% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -41.85% | -21.95% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.11% | 0.00% | |||||
| Dividend Growth | % | - | - | |||||
| Payout Ratio | % | -0.28% | -0.30% | |||||
| FCF/Debt | x | -0.00 | -0.16 | |||||
| Net Debt/EBITDA | x | -10.85 | -10.85 | |||||
| EBIT/Net interest | x | -0.43 | -0.43 | |||||
| Net debt/market cap | % | 225.27% | 1425.6% | |||||
| Net debt/Equity | x | 4.28 | 4.97 | |||||
| Gross debt/equity | x | 4.29 | 4.99 | |||||
Company overview
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. is a Chinese enterprise dedicated to the research, development, manufacturing, and distribution of both traditional Chinese medicines and advanced gene sequencing equipment. Its pharmaceutical offerings are diverse, encompassing ginseng-based medications, prescription drugs, and over-the-counter (OTC) remedies. These products are available in a broad spectrum of dosage forms, including pills, tablets, hard and soft capsules, various oral liquids (such as solutions and mixtures), granules, and lozenges. The company was established in 1998 and operates from its headquarters in Changchun, China.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. (002118.SZ)
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. is a Chinese enterprise dedicated to the research, development, manufacturing, and distribution of both traditional Chinese medicines and advanced gene sequencing equipment. Its pharmaceutical offerings are diverse, encompassing ginseng-based medications, prescription drugs, and over-the-counter (OTC) remedies. These products are available in a broad spectrum of dosage forms, including pills, tablets, hard and soft capsules, various oral liquids (such as solutions and mixtures), granules, and lozenges. The company was established in 1998 and operates from its headquarters in Changchun, China.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free